ANGIOGENIC INHIBITORY COMPOUNDS

摘要

A method of prophylactic or therapeutic inhibition of angiogenesis in a human or non-human animal patient, comprises administration to the patient of an effective amount of a compound selected from: (i) linear, non-carbohydrate polymers having a plurality of side chain groups wherein at least one of the side chain groups has an anionic- or cationic-containing moiety bonded or linked thereto; and (ii) dendrimers having a plurality of terminal groups wherein at least one of the terminal groups has an anionic- or cationiccontaining moiety bonded or linked thereto.